Jia Jie Biomedical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
May 11, 2022
Share
Jia Jie Biomedical Co., Ltd. reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was TWD 76.31 million compared to TWD 54.02 million a year ago. Net loss was TWD 2.05 million compared to TWD 3.01 million a year ago. Basic loss per share from continuing operations was TWD 0.02 compared to TWD 0.03 a year ago. Diluted loss per share from continuing operations was TWD 0.02 compared to TWD 0.03 a year ago.
Jia Jie Biomedical Co Ltd is a Taiwan-based company mainly engaged in the processing, production and distribution of turtles and turtle processed products. The Company operates through two business segments. Taiwan Operation segment is engaged in the production and sale of health foods. China Mainland Operation segment is engaged in the production of water purification equipment and related parts. Products are include nutrition and health care series, health water series, home supplies series. Products are mainly sold to Taiwan and mainland China.